ATC Group: V10XA01 Sodium iodide (131I)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V10XA01 in the ATC hierarchy

Level Code Title
1 V Various
2 V10 Therapeutic radiopharmaceuticals
3 V10X Other therapeutic radiopharmaceuticals
4 V10XA Iodine (131I) compounds
5 V10XA01 Sodium iodide (131I)

Active ingredients in V10XA01

Active Ingredient Description
Sodium iodide ¹³¹I

Iodide is actively transported by the sodium-iodide symporter (NIS) protein, in thyroid follicular cells. Sodium iodide ¹³¹I is used for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. The beta emission of I 131 is responsible for the therapeutic effect.

Medicines in this ATC group

Austria (AT)

Cyprus (CY)

Estonia (EE)

France (FR)

Hong Kong (HK)

Lithuania (LT)

Malta (MT)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.